Tips for setting expectations, a handy new year checklist, and February events.
Important Safety Information | Prescribing Information
Having trouble viewing this email? View Web Version
Novo Nordisk® Norditropin® (somatropin) injection 5 mg, 10 mg, 15 mg, 30 mg pens
Looking back and
moving forward.
This time of year, we often reflect on where we’ve been and look forward to the new year to come.
If you're the parent of a child using Norditropin®, you might be looking back at the growth they may have experienced and talking about the possibilities of growth still to come.
It’s important that children understand that seeing results from growth hormone therapy takes time and growth happens at a different pace for everyone. Talk to your doctor for insights specific to your child and check out our tips on setting realistic expectations, when to look for growth, and how long treatment may last.
Show Me Tips
Here’s a handy tool:
Growth Track Wizard.
Get a quick summary of your child’s growth. Just enter their measurements and go!
Take Me to the Wizard
Selected Important Safety Information
Do not use Norditropin® if: you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems; you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea; you have cancer or other tumors; you are allergic to somatropin or any of the ingredients in Norditropin®; your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy); you are a child with closed bone growth plates (epiphyses).
Please see additional Important Safety Information below.
Please click here for Prescribing Information.
 
Planning for the new year with NordiCare®.
NordiCare® offers several programs for qualifying families to help with co-pays and other out-of-pocket costs. Here’s a checklist to help with planning for the new year:
  Review your insurance coverage for 2019
  Check into pre-authorization requirements for a new plan
  Find out if re-authorization is required for your current plan
  Ask us about the NordiSure™ Co-pay Assistance Programa
  Already enrolled in NordiSure™? Check on your eligibility to re-enroll for next year
NordiCare® can help with these to-dos—and much more. Just give us a call at
1-888-NOVO-444 (1-888-668-6444) between 9 am and 5 pm Eastern time, Monday–Friday. Or go to NordiCare.com any time.
aCard covers costs including but not limited to co-pay/coinsurance to a maximum of $4000 per year of therapy. Offer excludes full cash-paying customers. Patients must be enrolled in a commercial insurance plan. Eligible patients must meet certain income requirements and have a co-pay greater than $1500 toward which they must pay the first $75. Card may be used for a maximum of 12 Norditropin® prescription fills. Card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs that reimburse the patient for the entire cost of his or her prescription drugs. Not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by any government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including managed Medicaid programs or Medicaid as secondary insurance. The program cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription. Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law. Absent a change in Massachusetts law, effective July 1, 2019, the Savings Card will no longer be valid for residents of Massachusetts. Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program. Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms. This is not an insurance program. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible. Must have a current prescription for an FDA-approved indication.
 
Finding support.
In this video, Sara and her mom, Leslie, share their story about how Sara was diagnosed with Turner syndrome and their experience with Norditropin®. Leslie also explains how helpful it’s been to connect with other families whose children are living with Turner syndrome.
Meet Sara and Leslie
“We attended the Turner Syndrome Society Conference and it was really eye-opening. My best experience there was talking to other moms.”
–Leslie, mom of Sara
February is all about awareness.
It may be a short month, but February is a great time to help others learn about Turner syndrome, Noonan syndrome, and other genetic disorders.
 
Turner Syndrome Awareness Month
 
February 29, 2019 is Rare Disease Day
 
Noonan Syndrome Awareness Month
Find more information through these resources:
Turner Syndrome Society, Rare Disease Day, Noonan Syndrome Foundation
 
Indications and Usage
What is Norditropin® (somatropin) injection?
Norditropin® is a prescription medicine that contains human growth hormone and is used to treat:
• children who are not growing because of low or no growth hormone
• children who are short (in stature) and who have Noonan syndrome or Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years
• children who have Idiopathic Short Stature (ISS)
• children who are not growing who have Prader-Willi syndrome (PWS)
• adults who do not make enough growth hormone
Important Safety Information (cont’d)
Do not use Norditropin® if:
• you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems
• you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea
• you have cancer or other tumors
• you are allergic to somatropin or any of the ingredients in Norditropin®
• your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy)
• you are a child with closed bone growth plates (epiphyses)
Before taking Norditropin®, tell your healthcare provider about all of your medical conditions, including if you:
• have had heart or stomach surgery, trauma or serious breathing (respiratory problems)
• have had a history of problems breathing while you sleep (sleep apnea)
• have or have had cancer or any tumor
• have diabetes
• are pregnant or breastfeeding, or plan to become pregnant or breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Norditropin® may affect how other medicines work, and other medicines may affect how Norditropin® works.
How should I use Norditropin®?
• Use Norditropin® exactly as your health care provider tells you to
• Do not share your Norditropin® pen and needles with another person. You may give another person an infection or get an infection from them.
What are the possible side effects of Norditropin®?
Norditropin® can cause serious side effects, including:
• high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problem
• high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea
• increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Contact the healthcare provider if you or your child start to have headaches, or have changes in behavior, changes in vision, or changes in moles, birthmarks, or the color of your skin
• new or worsening high blood sugar (hyperglycemia) or diabetes
• increase in pressure in the skull (intracranial hypertension). If you or your child has headaches, eye problems, nausea or vomiting, contact the healthcare provider
• serious allergic reactions. Get medical help right away if you or your child has the following symptoms: swelling of your face, lips, mouth or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, or sweating
• your body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your joints or muscles or nerve problems that cause pain, burning, or tingling in the hands, arms, legs and feet. Tell your healthcare provider if you have any of these signs or symptoms of fluid retention
• decrease in a hormone called cortisol. Tell your or your child’s healthcare provider if you or your child has darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
• decrease in thyroid hormone levels
• hip and knee pain or a limp in children (slipped capital femoral epiphysis)
• worsening of pre-existing curvature of the spine (scoliosis)
• severe and constant abdominal pain can be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
• loss of fat and tissue weakness in the area of skin you inject
• increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood
The most common side effects of Norditropin® include:
• injection site reactions and rashes, and headaches
Please click here for Norditropin® Prescribing Information.
Norditropin® is a prescription medication.
Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Talk to your health care provider and find out if Norditropin® is right for you or your child.
 
Having trouble viewing this email? View Web Version
 
PLEASE DO NOT RESPOND TO THIS EMAIL
UNSUBSCRIBE NOTICE
To unsubscribe from future communications from Novo Nordisk Inc., please click here. Additionally, you can unsubscribe from future Novo Nordisk communications by calling 1-877-744-2579 or sending a brief note with your name and address to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536.
Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
FlexPro® and Norditropin® are registered trademarks of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S. All other trademarks, registered or unregistered, are the property of their respective owners.
© 2018 Novo Nordisk  All rights reserved.  US18NORD00150  November 2018
Novo Nordisk®